Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

DEFM14C - Definitive information statement relating to merger or acquisition

Form Type: DEFM14C

Filing Date: 2024-03-05

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2024-02-23

View Filing

PREM14C - Preliminary information statements relating to merger or acquisition

Form Type: PREM14C

Filing Date: 2024-02-20

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2024-02-14

View Filing

SC 13D/A [Amend] - General Statement of Acquisition of Beneficial Ownership

Form Type: SC 13D/A

Filing Date: 2024-02-12

View Filing

SC 13G/A [Amend] - Statement of Beneficial Ownership by Certain Investors

Form Type: SC 13G/A

Filing Date: 2024-02-12

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2024-02-09

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2024-02-06

View Filing

8-K/A [Amend] - Current report

Form Type: 8-K/A

Filing Date: 2024-01-03

View Filing

SC 13D/A [Amend] - General Statement of Acquisition of Beneficial Ownership

Form Type: SC 13D/A

Filing Date: 2023-11-21

View Filing